ASTH vs ELV
ASTH: Astrana Health operates a technology-driven platform that empowers independent physicians and medical groups to transition to and succeed in value-based care models. ELV: Elevance Health is a leading health benefits and services organization providing comprehensive medical, pharmacy, and integrated clinical care solutions to millions of members.
Side-by-side fundamentals
| Metric | ASTH | ELV | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $41.94 | $389.09 | |
| Market cap as of 2026-07-23 | $2.1B | $85.3B | |
| P/E as of 2026-07-23 | 70.92 | 17.18 | ELV lower |
| PEG as of 2026-07-23 | n/a | 3.60 | |
| Net margin as of 2026-07-23 | +0.9% | +2.5% | ELV higher |
| Gross margin as of 2026-07-23 | +10.7% | n/a | |
| Operating margin as of 2026-07-23 | +2.5% | +3.6% | ELV higher |
| ROE as of 2026-07-23 | +3.9% | +11.2% | ELV higher |
| ROA as of 2026-07-23 | +1.5% | +4.0% | ELV higher |
| Debt / equity as of 2026-07-23 | 1.28 | 0.69 | ELV lower |
| Revenue growth (YoY) as of 2026-07-23 | +56.7% | +6.3% | ASTH higher |
| Revenue CAGR (3y) SEC XBRL | +40.6% | +8.3% | ASTH higher |
| Dividend yield as of 2026-07-23 | +0.1% | +1.7% | ELV higher |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-23 | 0.87 | 0.69 | |
| 1-year return as of 2026-07-22 close | +97.3% | +42.3% | ASTH higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.